GW29-e0242 Evaluation of drug release from paclitaxel+hirudin-eluting balloons and the resulting vascular reactivity in healthy pigs

Although the development of the drug-eluting stent (DES) is a milestone in the field of interventional cardiovascular treatment, 20%-30% of patients suffer from restenosis within 3 months after surgery. This study explored the drug release frompaclitaxel+hirudin-eluting balloons in a healthy pig